💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests

Published 01/31/2019, 02:41 AM
© Reuters. A bottle of Johnson's Baby Powder is seen in a photo illustration taken in New York
JNJ
-

COLOMBO (Reuters) - Sri Lanka has halted imports of Johnson & Johnson (NYSE:JNJ) Baby Powder until the company proves its product is free from cancer-causing asbestos, two government officials and the product's local distributor told Reuters.

Stocks of the product already in Sri Lanka can still be sold, but there will be no new imports of the talc, a popular healthcare product across Sri Lanka and much of Asia, until J&J India, from where Sri Lanka imports the product, provides fresh test results.

On Dec. 14, Reuters reported that the U.S. drugs and consumer products group knew for decades that asbestos lurked in its Baby Powder, leading to tests in several countries, including in India.

The report was based on thousands of pages of company memos, internal reports, and other confidential documents.

J&J has described the Reuters story as "one-sided, false, and inflammatory".

Kamal Jayasinghe, chief executive of Sri Lanka's National Medicine Regulatory Authority (NMRA), which is part of the health ministry, said it had informed the distributor, A.Baur & Co., that it would require further tests for it to continue importing the powder.

"We have held their re-registration and informed the distributor to submit quality reports from an accredited laboratory to ensure there is no asbestos in their products,” Jayasinghe told Reuters.

The license for A.Baur & Co to import the product expired in December, a second person at the NMRA said.

Shalutha Perera, head of consumer for A.Baur, told Reuters the firm has informed J&J in India of the suspension of the licensing process.

"J&J India directly handles all the regulatory matters," he said.

Perera said the NMRA contacted A.Baur in December regarding new asbestos testing.

A spokeswoman for J&J India declined to comment on the halt of shipments to Sri Lanka but said the company "is in full compliance with current Indian regulatory requirements for the manufacturing and testing of our talc".

"We are fully cooperating with the Indian government and are awaiting results from their testing," she added.

© Reuters. A bottle of Johnson's Baby Powder is seen in a photo illustration taken in New York

The spokeswoman said the product was routinely tested by both suppliers and independent labs to ensure it is free of asbestos.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.